Seres Therapeutics, Inc. (MCRB) Form 8-K — Aug 4, 2026
Seres Therapeutics entered into a Third Amendment to Lease and Termination Agreement with landlord BMR-Sidney Research Campus LLC on July 31, 2026, ending its lease at 200 Sidney Street in Cambridge, Massachusetts roughly four years ahead of schedule. The company said the deal reduces its ongoing annual facilities costs and materially eliminates its primary restoration obligations. Effective August 1, 2026, Seres surrenders approximately 21,295 rentable square feet, and the remaining 47,341 square feet now expire December 31, 2026 instead of January 13, 2031.
Key figures
- Sqft remaining
- 47341
- New lease expiration
- December 31, 2026
- Prior lease expiration
- January 13, 2031
- Sqft original premises
- 68636
- Share issuance price usd
- 4.83
- Share issuance value usd
- $500,001.60
- Termination fee due date
- January 4, 2027
- Lease termination fee usd
- 3850000
- Shares issued to landlord
- 103520
- Sqft surrendered aug 2026
- 21295
- Total stated consideration usd
- approximately $6.59 million (sum of $2,238,415.84 LC increase + $3,850,000 termination fee + ~$500,000 equity issuance)
Price after filing
Close on the filing date to close N calendar days later (from $5.25). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.